MX2024004872A - Formulaciones farmaceuticas. - Google Patents
Formulaciones farmaceuticas.Info
- Publication number
- MX2024004872A MX2024004872A MX2024004872A MX2024004872A MX2024004872A MX 2024004872 A MX2024004872 A MX 2024004872A MX 2024004872 A MX2024004872 A MX 2024004872A MX 2024004872 A MX2024004872 A MX 2024004872A MX 2024004872 A MX2024004872 A MX 2024004872A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical formulations
- relates
- liquid pharmaceutical
- antibodies
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2115121.2A GB202115121D0 (en) | 2021-10-21 | 2021-10-21 | Formulations |
| PCT/EP2022/079182 WO2023067049A1 (en) | 2021-10-21 | 2022-10-20 | Formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024004872A true MX2024004872A (es) | 2024-05-06 |
Family
ID=78806158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024004872A MX2024004872A (es) | 2021-10-21 | 2022-10-20 | Formulaciones farmaceuticas. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240415769A1 (https=) |
| EP (1) | EP4419078A1 (https=) |
| JP (1) | JP2024539265A (https=) |
| KR (1) | KR20240099311A (https=) |
| CN (1) | CN118119377A (https=) |
| AR (1) | AR127421A1 (https=) |
| AU (1) | AU2022372646A1 (https=) |
| CA (1) | CA3235381A1 (https=) |
| CL (1) | CL2024001229A1 (https=) |
| CO (1) | CO2024006193A2 (https=) |
| GB (1) | GB202115121D0 (https=) |
| GE (2) | GEAP202416520A (https=) |
| IL (1) | IL312207A (https=) |
| MX (1) | MX2024004872A (https=) |
| PE (1) | PE20241193A1 (https=) |
| TW (1) | TW202323288A (https=) |
| WO (1) | WO2023067049A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006100679A2 (en) | 2005-03-22 | 2006-09-28 | Quark Pharmaceuticals, Inc. | Recombinant antibodies against human type ii transglutaminase and uses thereof |
| GB2490655A (en) | 2011-04-28 | 2012-11-14 | Univ Aston | Modulators of tissue transglutaminase |
| GB201209096D0 (en) | 2012-05-24 | 2012-07-04 | Medical Res Council Technology | Compounds |
| GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
| CN109563161A (zh) * | 2016-02-03 | 2019-04-02 | 安口生物公司 | 用于提高抗体稳定性的缓冲制剂 |
-
2021
- 2021-10-21 GB GBGB2115121.2A patent/GB202115121D0/en not_active Ceased
-
2022
- 2022-10-20 JP JP2024524494A patent/JP2024539265A/ja active Pending
- 2022-10-20 US US18/703,661 patent/US20240415769A1/en active Pending
- 2022-10-20 MX MX2024004872A patent/MX2024004872A/es unknown
- 2022-10-20 CN CN202280070135.8A patent/CN118119377A/zh active Pending
- 2022-10-20 GE GEAP202416520A patent/GEAP202416520A/en unknown
- 2022-10-20 KR KR1020247016530A patent/KR20240099311A/ko active Pending
- 2022-10-20 AR ARP220102861A patent/AR127421A1/es unknown
- 2022-10-20 IL IL312207A patent/IL312207A/en unknown
- 2022-10-20 TW TW111139753A patent/TW202323288A/zh unknown
- 2022-10-20 GE GEAP202216520A patent/GEP20257800B/en unknown
- 2022-10-20 EP EP22817522.0A patent/EP4419078A1/en active Pending
- 2022-10-20 PE PE2024000910A patent/PE20241193A1/es unknown
- 2022-10-20 CA CA3235381A patent/CA3235381A1/en active Pending
- 2022-10-20 WO PCT/EP2022/079182 patent/WO2023067049A1/en not_active Ceased
- 2022-10-20 AU AU2022372646A patent/AU2022372646A1/en active Pending
-
2024
- 2024-04-19 CL CL2024001229A patent/CL2024001229A1/es unknown
- 2024-05-16 CO CONC2024/0006193A patent/CO2024006193A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022372646A1 (en) | 2024-06-06 |
| GEAP202416520A (en) | 2024-07-25 |
| AR127421A1 (es) | 2024-01-24 |
| GB202115121D0 (en) | 2021-12-08 |
| GEP20257800B (en) | 2025-09-25 |
| CN118119377A (zh) | 2024-05-31 |
| JP2024539265A (ja) | 2024-10-28 |
| TW202323288A (zh) | 2023-06-16 |
| CA3235381A1 (en) | 2023-04-27 |
| KR20240099311A (ko) | 2024-06-28 |
| US20240415769A1 (en) | 2024-12-19 |
| PE20241193A1 (es) | 2024-06-03 |
| IL312207A (en) | 2024-06-01 |
| EP4419078A1 (en) | 2024-08-28 |
| CL2024001229A1 (es) | 2024-09-13 |
| CO2024006193A2 (es) | 2024-05-30 |
| WO2023067049A1 (en) | 2023-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR114922A1 (es) | Moléculas que tienen utilidad plaguicida, y composiciones y procesos, relacionados con ellas | |
| UY37513A (es) | Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador | |
| ECSP22032851A (es) | Inhibidores del fxia y m?todo de preparaci?n de los mismos y uso farmac?utico de los mismos | |
| CR20200452A (es) | Compuestos de aminoacidos y métodos de uso | |
| AR103561A1 (es) | Fenilpiridinas herbicidas | |
| EA201800064A1 (ru) | 1,1,1-трифтор-3-гидроксипропан-2-ил карбаматные производные и 1,1,1-трифтор-4-гидроксибутан-2-ил карбаматные производные в качестве ингибиторов magl | |
| ECSP055918A (es) | Procedimiento para modificar la formación de cristal de fármaco | |
| UY30681A1 (es) | Compuestos de piridinamida que contienen carboxi, sales farmacéuticamente aceptables, procedimientos para la preparacion de los mismos, composiciones que los contienen y sus usos. | |
| AR119097A1 (es) | Métodos de purificación de anticuerpos enmascarados | |
| AR084433A1 (es) | Inhibidores de la faah y composiciones farmaceuticas que los contienen | |
| MX2021010875A (es) | Composiciones de éster de ácido cannabinoide y sus usos. | |
| CL2018000622A1 (es) | Acetamida tienodiazepinas de triazol y sus usos relacionados. | |
| PY2031844A (es) | Compuestos y métodos que inhiben eif4e | |
| CR8216A (es) | Formula liquida para la proteccion de las plantas | |
| CL2021003568A1 (es) | Compuestos heteroaromáticos como inhibidores de vanina (divisional de solicitud n° 202101198) | |
| PE20212323A1 (es) | Formulaciones farmaceuticas | |
| MX2019012967A (es) | Cristal de base libre de derivados benzofurano y metodo de preparacion. | |
| CU24707B1 (es) | Inihibidores del factor d del complemento para administración oral | |
| CO2024006193A2 (es) | Formulaciones farmacéuticas | |
| CO2024006206A2 (es) | Composiciones farmacéuticas | |
| JOP20240074A1 (ar) | تركيبات إنزالوتاميد سائلة فموية | |
| UY40050A (es) | Formulaciones para anticuerpos pegilados | |
| MX2021004647A (es) | Formas cristalinas de moduladores de los canales de potasio. | |
| GT200600421A (es) | Formas cristalinas polimórficas de la sal de di-sodio del ácido n-(5-clorosaliciloil)-8-aminocaprilico | |
| EA201990791A1 (ru) | Производные 5-замещенного имидазолилметилдиоксолана в качестве фунгицидов |